Can High-Dose vitamin c boost Chemo's punch against pancreatic cancer?

NCT ID NCT03410030

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This trial is testing whether adding high-dose vitamin C (ascorbic acid) to a standard three-drug chemotherapy cocktail can safely and effectively control metastatic pancreatic cancer in people who have not yet received any treatment. The study enrolls adults with stage IV pancreatic cancer and aims to find the best dose of vitamin C that can be given alongside the chemo. Researchers are watching for tumor shrinkage and how long the disease stays stable.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
high-dose vitamin C (ascorbic acid) plus a combination of chemotherapy drugs: nab-paclitaxel, cisplatin, and gemcitabine
What this could lead to
If it works, this could point toward a more effective first-line treatment for metastatic pancreatic cancer, a disease with very few good options.
What could go wrong
This is an early-phase trial with only 17 participants, so results may not apply broadly. High-dose vitamin C can cause kidney stones and other side effects, and the chemo combination itself is intense.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREAS CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • HonorHealth Research Institute

    Scottsdale, Arizona, 85258, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.